BioCentury
ARTICLE | Clinical News

Norelin: Began Phase I/II trial

February 22, 1999 8:00 AM UTC

Biostar Inc., Saskatoon, Saskatchewan Product: Norelin Business: Cancer Therapeutic category: Immune stimulation Target: Gonadotropin-releasing hormone (GnRH) Description: Therapeutic vaccine against ...